PROTXX innovations in wearable sensors and machine learning transform the lives of tens of millions of people with complex neurophysiological medical conditions such as concussions, stroke, multiple sclerosis, and Parkinson’s disease. These conditions can result from injuries, disease, aging, or genetic disorders, and can lead to impairments to multiple physiological systems. Current solutions for diagnosing these multiple impairments and monitoring the effectiveness of treatments and rehabilitation require multiple time-consuming tests carried out by multiple clinical specialists using expensive lab equipment. The PROTXX PHYsiological viBRATion Acceleration (PHYBRATA) sensor delivers an innovative solution to this problem by enabling much easier to use, lower cost, in-clinic-and remote assessments and management of these multiple impairments. The PHYBRATA sensor attaches behind the ear using a small disposable adhesive and detects microscopic involuntary motions of the body. Our powerful machine learning engine identifies and analyzes the different contributions made by each of the body’s physiological systems, allowing a one-minute, non-invasive PHYBRATA test to quantify and monitor impairments using the unique biomechanical vibrational signature of each physiological system. The PHYBRATA sensor, mobile app, and cloud-based data services have been integrated into a platform-as-a-service solution licensed to healthcare delivery and research organizations.

PROTXX, Inc.

Org chart

Similar companies